Narender Tadigoppula

Title: Narender Tadigoppula: Innovator in Pharmaceutical Composition

Introduction

Narender Tadigoppula is a notable inventor based in Lucknow, India. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of diabetes and dyslipidemia. His innovative work has led to the development of a unique bioactive fraction that holds promise for medical applications.

Latest Patents

Narender Tadigoppula holds 1 patent for his invention titled "Pharmaceutical composition for treatment of diabetes and dyslipidemia." This patent describes a bioactive fraction that is beneficial for treating diabetes and dyslipidemia. The composition can be utilized as an antidiabetic and antidyslipidemic agent. Additionally, it outlines a process for preparing this bioactive fraction from isomeric xyloccensins, along with pharmaceutical compositions that include therapeutically effective amounts of these compounds.

Career Highlights

Narender Tadigoppula is affiliated with the Council of Scientific and Industrial Research, where he has been involved in groundbreaking research. His work focuses on developing pharmaceutical solutions that address critical health issues, particularly those related to metabolic disorders.

Collaborations

Some of his notable coworkers include Vijai Lakshmi and Ajet Saxena. Their collaborative efforts contribute to the advancement of research in the pharmaceutical field.

Conclusion

Narender Tadigoppula's innovative contributions to pharmaceutical compositions demonstrate his commitment to improving health outcomes for individuals suffering from diabetes and dyslipidemia. His work exemplifies the importance of research and innovation in addressing pressing medical challenges.